Loading...
The risk of early and late cytomegalovirus DNAemia associated with Campath use in stem cell transplant recipients
The risks associated with in vivo and ex vivo use of Campath-1H and -1G in a cohort of 206 stem cell transplant recipients for cytomegalovirus (HCMV) DNAemia have been quantified. DNAemia showed a biphasic incidence pattern with an inflexion at day 60. The first phase had a linear risk rate for HCMV...
Na minha lista:
| Udgivet i: | Bone Marrow Transplant |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4829098/ https://ncbi.nlm.nih.gov/pubmed/19966846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2009.329 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|